Drospirenone And Ethinyl Estradiol
Product Images NDC 61916-090

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 61916-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaceutics International, Inc. (pii), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Dro02 0006 01)

A forest plot illustrating hazard ratios, rate ratios, or odds ratios from multiple studies including Ingenix, EURAS, LASS, FDA-funded, Danish, MEGA, German case-control, PharMetrics, and GPRD studies. The graph compares risk estimates on a logarithmic scale from 0.1 to 10, categorizing studies as prospective cohort, retrospective cohort, case-control, or non-fatal idiopathic cases only.*

FDA Label Image

Figure 2 (Dro02 0006 02)

A horizontal bar chart showing the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC user (1 to 5), COC-User (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range (40 to 65). A note below explains the pregnancy data is based on actual pregnancy duration and a nine-month model assumption.*

FDA Label Image

Figure (Dro02 0006 03)

Chemical structure diagrams of Drospirenone and Ethinyl estradiol, the active ingredients in the product. The left structure shows Drospirenone and the right structure shows Ethinyl estradiol, both labeled below their respective diagrams.*

FDA Label Image

Pii Logo (Dro02 0006 04)

FDA Label Image

Figure (Dro02 0006 05)

A vertical effectiveness chart of contraceptive methods showing the number of pregnancies per 100 women per year. It lists methods from most effective (implants, injections, intrauterine devices, sterilization) at the top to least effective (no birth control) at the bottom, with birth control pills, skin patch, and vaginal ring, condoms and diaphragm, and behavioral methods in between.*

FDA Label Image

Figure (Dro02 0006 06)

Blister card for Drospirenone and Ethinyl Estradiol Tablets, USP 3 mg/0.02 mg, arranged in four rows of 7 circular tablet slots each. The label includes the active ingredients Drospirenone and Ethinyl Estradiol with their strength. The card has a designated area for placing the day label and arrows indicating the tablet order starting from the top left.*

FDA Label Image

Figure (Dro02 0006 07)

A horizontal bar chart showing the number of women with blood clots per 10,000 women years (WY) in four groups: Non-Pregnant Non-COC users (1 to 5), COC Users (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range (40 to 65). Notes below explain pregnancy data based on duration assumptions from reference studies.*

FDA Label Image

Principal Display Panel (Drospirenone and Ethinyl Estradiol Tablets Carton Label)

Drospirenone and Ethinyl Estradiol Tablets, USP 3 mg/0.02 mg packaging label for 3 blister packs of 28 tablets each. The label includes usage information, storage instructions, and a warning that the product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. Manufactured by Pharmaceutics International, Inc. (Pii), Hunt Valley, MD 21031 USA. The package NDC is 61916-090-30.*

FDA Label Image

Principal Display Panel (Drospirenone and Ethinyl Estradiol Tablets Label)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets, USP 3 mg/0.02 mg oral tablets by Pharmaceutics International, Inc. The box contains 28 tablets: 24 pink active tablets and 4 white inert tablets. The label includes storage instructions, usage details, and a barcode with NDC 61916-090-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.